NCT03827850
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03827850
Title FGFR Inhibitor in FGFR Dysregulated Cancer (FIND)
Acronym FIND
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Lung Cancer Group Cologne
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Asklepios Klinik München Gauting Gauting Bavaria 82131 Germany Details
Uniklinik Frankfurt Frankfurt am Main Hesse 60590 Germany Details
Städtisches Klinikum Braunschweig Braunschweig Lower Saxony 38114 Germany Details
Pius Hospital Oldenburg Oldenburg Lower Saxony 26121 Germany Details
Uniklinik RWTH Aachen - Klinik für Hämotologie, Onkologie Aachen North Rhine-Westphalia 52074 Germany Details
University Hospital of Cologne Cologne North Rhine-Westphalia 50937 Germany Details
Universitätsklinikum Würzburg Comprehensive Cancer center Würzburg North Rhine-Westphalia 97080 Germany Details
Uniklinik Carl Gustav Carus Dresden Dresden Saxony 01307 Germany Details
Evangelische Lungenklink Berlin Berlin 13125 Germany Details
Universitätsklinik Freiburg Freiburg im Breisgau 79106 Germany Details
Universitätsklinik des Saarlandes Homburg Homburg 66421 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field